Skip to main content
SpringerLink
Log in

Using molecular testing/whole-genome sequencing for TB diagnosis cost effective in low-burden setting

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Mugwagwa T, et al. Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling. Thorax : 4 Feb 2021. Available from: URL: http://doi.org/10.1136/thoraxjnl-2019-214004

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Using molecular testing/whole-genome sequencing for TB diagnosis cost effective in low-burden setting. PharmacoEcon Outcomes News 872, 29 (2021). https://doi.org/10.1007/s40274-021-7502-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7502-9

Search

Navigation